Stephen Wu

Title: The Innovations of Stephen Wu

Introduction

Stephen Wu is an accomplished inventor based in Fishers, Indiana. He has made significant contributions to the field of vaccine development, particularly in relation to swine health. With a total of 4 patents, his work has had a notable impact on the agricultural and veterinary sectors.

Latest Patents

One of Stephen Wu's latest patents is focused on the Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine virus. This invention involves modified, live PRRS viruses that have been genetically analyzed and selected for modification through repeated passage in tissue culture. The modified viruses are assessed for their ability to provide protective immunity against heterologous viruses, making them useful in vaccines that can treat infections in swine caused by multiple viruses.

Another significant patent relates to the inactivation of viruses by delipidation. This invention involves vaccines containing enveloped viruses whose envelopes have been depleted of lipids using methyl β-cyclodextrin (MBCD). The delipidation process effectively abolishes the infectivity of the viruses, allowing them to be safely used in vaccines. This method preserves the immunogenicity of the viral proteins while significantly reducing the cholesterol content of the viruses.

Career Highlights

Stephen Wu has worked with notable companies in the field, including Elanco US Inc. and Elanco UK Ah Limited. His experience in these organizations has contributed to his expertise in vaccine development and innovation.

Collaborations

Stephen has collaborated with talented individuals such as Ying Fang and Cinta Prieto Suarez, further enhancing the quality and impact of his work.

Conclusion

Stephen Wu's innovative contributions to vaccine development demonstrate his commitment to improving swine health through scientific advancements. His patents reflect a deep understanding of virology and immunology, positioning him as a key figure in the field.